Engaging new partners to save lives
The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion - comprised of preeminent global health experts - to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.
Panelists will provide their unique perspectives on:
-
How do these partnerships find success in the face of seemingly insurmountable challenges?
-
What have we learned from past successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
-
Where are the opportunities for the next big solutions?
-
Who is missing from the table in the effort to push back against HIV, TB, malaria and neglected tropical diseases?
-
Why should those outside the global health and NGO worlds join this effort?
The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.
When:6-8:30pm
November 12, 2013
Who:
Panelists:
-
Peter Piot, M.D., Ph.D.
Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member
-
Ann M. Veneman, J.D.
Former Executive Director of UNICEF; Former Secretary of Agriculture; GHIT Fund Board Member
-
Mel Spigelman, M.D.
President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee
-
Kiyoshi Kurokawa, M.D.
Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute
Moderated:
-
Ko-Yung Tung, J.D.
Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor
Where:
Japan Society
333 East 47th Street
New York, NY 10017